Results 71 to 80 of about 13,687 (277)

The face of Ebola: changing frequency of haemorrhage in the West African compared with Eastern-Central African outbreaks [PDF]

open access: yes, 2015
BACKGROUND: The West-African (WA) Zaire Ebolavirus disease (EVD) outbreak was characterized by an exceptionally high number of cases and deaths as compared with the Eastern-Central African (ECA) outbreaks.
Crispian Scully   +4 more
core   +4 more sources

Ebolavirus and Haemorrhagic Syndrome

open access: yesSultan Qaboos University Medical Journal, 2015
The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world's most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90% of patients.
Gerald A. Matua   +2 more
openaire   +4 more sources

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors

open access: yesmAbs, 2020
Ebola virus (EBOV) can cause severe hemorrhagic fever in humans, and no approved treatment is currently available. Although several antibodies have achieved good protection in animal models, the potential emerging isolates of ebolavirus and the unknown ...
Pengfei Fan   +12 more
doaj   +1 more source

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques

open access: yesEmerging Microbes and Infections, 2022
Due to its high mortality rate and continued re-emergence, Ebolavirus disease (EVD) continues to pose a serious threat to global health. A group of viruses within the genus Ebolavirus causes this severe hemorrhagic disease in humans: Ebola virus (EBOV ...
Courtney Woolsey   +10 more
semanticscholar   +1 more source

Ebolavirus diagnosis made simple, comparable and faster than molecular detection methods: preparing for the future

open access: yesVirology Journal, 2018
Background The 2014/2015 Ebolavirus outbreak resulted in more than 28,000 cases and 11,323 reported deaths, as of March 2016. Domestic transmission of the Guinea strain associated with the outbreak occurred mainly in six African countries, and ...
Ameh S. James   +4 more
doaj   +1 more source

Ebola Haemorrhagic Fever in Africa: a Necessary Highlight [PDF]

open access: yes, 2019
The purpose of this commentary is to re-evaluate the historic and scientific facts on Ebola haemorrhagic fever and the role of the International community, especially Economic Community of West African States (ECOWAS) in stemming the tide.
Adu-Gyamfi, S. (Samuel)
core   +3 more sources

The Molecular Genetic Peculiarities of Genomic Structure of Members of the Ebolavirus Genus

open access: yesПроблемы особо опасных инфекций, 2015
The molecular genetic peculiarities of genomic structure of the Ebolavirus genus members are viewed in the review. The Ebola virus disease outbreaks in West African countries constitute a threat not only for Africa, but for the whole world in view of ...
A. A. Petrov   +8 more
doaj   +1 more source

In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes

open access: yesVaccines, 2023
(1) Background and Purpose: Ebola virus (EBOV) is the causative agent of Ebola virus disease (EVD), which causes extremely high mortality and widespread epidemics.
Junqi Zhang   +17 more
semanticscholar   +1 more source

[Ebola virus (Filoviridae: Ebolavirus: Zaire ebolavirus): fatal adaptation mutations].

open access: yesVoprosy virusologii, 2021
Ebola virus disease (EVD) (former Ebola hemorrhagic fever) is one of the most dangerous infectious diseases affecting humans and primates. Since the identification of the first outbreak in 1976, there have been more than 25 outbreaks worldwide, the largest of which escalated into an epidemic in 2014-2016 and caused the death of more than 11,000 people.
I. V. Dolzhikova   +3 more
openaire   +2 more sources

Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis [PDF]

open access: yes, 2015
The 2013–2015 Ebolavirus disease humanitarian crisis has spurred the development of laboratory-free, point-of-care nucleic acid testing solutions.
Christie A   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy